Bone Marrow TransplantationBone MarrowTransplantation, AutologousBone Marrow CellsTransplantation, HomologousBone Marrow PurgingBone and BonesWhole-Body IrradiationGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideHematopoietic Stem Cell TransplantationBone Marrow DiseasesHematopoietic Stem CellsTransplantation ConditioningLymphoma, Non-HodgkinCarmustineLeukemiaBusulfanAnemia, AplasticGraft SurvivalHematopoiesisRemission InductionTreatment OutcomeMelphalanLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsBone Marrow ExaminationTransplantation ChimeraBone RemodelingRecurrenceColony-Forming Units AssayBone Marrow NeoplasmsEtoposideTissue DonorsLiver TransplantationTime FactorsHodgkin DiseaseTransplantation, IsogeneicLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibility TestingMice, Inbred C57BLStem Cell TransplantationCytarabineHistocompatibilitySurvival AnalysisBone DensityRadiation ChimeraActuarial AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAcute DiseaseFollow-Up StudiesHepatic Veno-Occlusive DiseaseImmunosuppressive AgentsHematologic DiseasesBone ResorptionKidney TransplantationT-LymphocytesMyelodysplastic SyndromesRetrospective StudiesLymphomaMultiple MyelomaGranulocyte Colony-Stimulating FactorCell DifferentiationSurvival RateBone TransplantationLeukocyte CountDrug EvaluationImmunosuppressionDisease-Free SurvivalVincristineHematologic NeoplasmsThiotepaAntigens, CD34Cells, CulturedGraft RejectionPodophyllotoxinGranulocytesSalvage TherapyFlow CytometryBone NeoplasmsPrognosisGraft vs Host ReactionLymphocyte DepletionTransplantation ImmunologyAntibodies, MonoclonalCell SeparationCyclosporineChimeraLeukocyte TransfusionGranulocyte-Macrophage Colony-Stimulating FactorBlood Cell CountProspective StudiesPlatelet CountSevere Combined ImmunodeficiencySpleenHLA AntigensStromal CellsPancytopenia